Target intelligence / Profile preview

Bacterial outer membrane and cytoplasmic membrane (OM/CM)

Target
OM/CM
Molecular classification
Cellular structure, Lipid bilayer, Biological barrier
01

Overview

The bacterial cell envelope, comprising the cytoplasmic (inner) membrane and, in Gram-negative bacteria, an additional outer membrane, serves as a critical protective barrier and metabolic hub (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). The cytoplasmic membrane is a phospholipid bilayer responsible for essential processes such as nutrient transport, energy generation via the electron transport chain, and lipid biosynthesis (Epand et al., 2016, Biochim Biophys Acta). In Gram-negative species, the outer membrane contains lipopolysaccharides (LPS) and porins, acting as a selective permeability barrier against toxic compounds, including many antibiotics (Nikaido, 2003, Microbiol Mol Biol Rev). Drugs targeting these membranes, such as polymyxins and lipopeptides, typically act by disrupting the structural integrity or electrical potential of the lipid bilayers, leading to rapid cell death (Straus & Hancock, 2006, Biochim Biophys Acta). While highly effective against multi-drug resistant pathogens, these agents often face challenges regarding systemic toxicity due to similarities between bacterial and mammalian membrane components or off-target effects (Baron et al., 2016, Int J Antimicrob Agents). Resistance can also emerge through membrane remodeling or modifications to LPS, posing a significant challenge in treating multi-drug resistant infections.

Other names
Bacterial cell envelopeBacterial cell membraneInner and outer membranesCytoplasmic and outer membranesPlasma membrane
02

Mechanism of action

Disruption of membrane integrity through binding to lipopolysaccharides or phospholipids, leading to pore formation, depolarization, and leakage of intracellular contents.

03

Biological functions

Selective permeabilityEnergy transductionNutrient transportCell wall biosynthesisSignal transduction
04

Disease associations

Bacterial infectionSepsisAntimicrobial resistance
05

Safety considerations

NephrotoxicityNeurotoxicityMyopathyElectrolyte imbalanceDevelopment of resistance
06

Interacting drugs

Polymyxin B

6 more in the full profile.

07

Biomarkers

ProcalcitoninC-reactive proteinBacterial DNA loadLactate

Beyond the preview

Go deeper on Bacterial outer membrane and cytoplasmic membrane (OM/CM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial outer membrane and cytoplasmic membrane (OM/CM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call